What the Evidence Actually Shows The efficacy signal for semaglutide in weight management is unusually strong for pharmacology, and it is worth being precise about what kind of evidence it is
consider reducing doses of these medications when initiating tirzepatide Signs of acute kidney injury, particularly in patients experiencing severe gastrointestinal adverse effects with dehydration Symptoms of pancreatitis (severe abdominal pain radiating to the back, nausea, vomiting) Gallbladder disease (right upper quadrant pain, fever, jaundice) Gastrointestinal adverse effects, which occur commonly but are usually self-limited Tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis
Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2
Phase 3 trials are ongoing and no version is approved for prescription use in the UK
Clinical Update 7/09/2024 Alpha-Lipoic Acid & Low Blood Sugar Although rare, alpha-lipoic acid may trigger an autoimmune condition that causes low blood sugar, as highlighted in a recent case
